Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis
Open Access
- 5 April 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7), 2523
- https://doi.org/10.3390/ijms21072523
Abstract
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) regulates target gene expression upon ligand binding. Apart from its effects on metabolism, PPARγ activity can inhibit the production of pro-inflammatory cytokines by several immune cells, including dendritic cells and macrophages. In chronic inflammatory disease models, PPARγ activation delays the onset and ameliorates disease severity. Here, we investigated the effect of PPARγ activation by the agonist Pioglitazone on the function of hepatic immune cells and its effect in a murine model of immune-mediated hepatitis. Cytokine production by both liver sinusoidal endothelial cells (IL-6) and in T cells ex vivo (IFNγ) was decreased in cells from Pioglitazone-treated mice. However, PPARγ activation did not decrease pro-inflammatory tumor necrosis factor alpha TNFα production by Kupffer cells after Toll-like receptor (TLR) stimulation ex vivo. Most interestingly, although PPARγ activation was shown to ameliorate chronic inflammatory diseases, it did not improve hepatic injury in a model of immune-mediated hepatitis. In contrast, Pioglitazone-induced PPARγ activation exacerbated D-galactosamine (GalN)/lipopolysaccharide (LPS) hepatitis associated with an increased production of TNFα by Kupffer cells and increased sensitivity of hepatocytes towards TNFα after in vivo Pioglitazone administration. These results unravel liver-specific effects of Pioglitazone that fail to attenuate liver inflammation but rather exacerbate liver injury in an experimental hepatitis model.Funding Information
- Deutsche Forschungsgemeinschaft (SFB704 A5, SFB841 B01, SFB841 B09)
This publication has 42 references indexed in Scilit:
- Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsisInnate Immunity, 2013
- The Role of T cell PPAR γ in mice with experimental inflammatory bowel diseaseBMC Gastroenterology, 2010
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunityThe Journal of Experimental Medicine, 2009
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunityThe Journal of Experimental Medicine, 2009
- Systemic PPARγ Ligation Inhibits Allergic Immune Response in the SkinJournal of Investigative Dermatology, 2008
- Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell toleranceJournal of Hepatology, 2007
- PPARγ in immunity and inflammation: cell types and diseasesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in miceJournal of Hepatology, 2007
- Importance of Kupffer Cells for T-Cell-Dependent Liver Injury in MiceThe American Journal of Pathology, 2000
- Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized miceGastroenterology, 1996